US Patent Issued to Sichuan Kelun-Biotech Biopharmaceutical, Klus Pharma on March 25 for "Anti-FXI/FXIa antibody and use thereof" (Chinese, American Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,419, issued on March 25, was assigned to Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. (Chengdu, China) and Klus Pharma Inc. (Cranbury, N.J.).

"Anti-FXI/FXIa antibody and use thereof" was invented by Haijun Tian (Cranbury, N.J.), Dengnian Liu (Chengdu, China), Sujun Deng (Cranbury, N.J.), Marc Peter Ciucci (Cranbury, N.J.), Cheng Wang (Chengdu, China), Yong Zheng (Chengdu, China), Liang Xiao (Chengdu, China), Tongtong Xue (Chengdu, China) and Jingyi Wang (Chengdu, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the field of therapeutic monoclonal antibodies, and specifically provides an anti-FXI/FXIa antibod...